Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance - PubMed (original) (raw)
. 2006 Jun;290(6):H2196-203.
doi: 10.1152/ajpheart.01017.2005. Epub 2006 Feb 10.
Affiliations
- PMID: 16473959
- DOI: 10.1152/ajpheart.01017.2005
Free article
Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance
Mark F Berry et al. Am J Physiol Heart Circ Physiol. 2006 Jun.
Free article
Abstract
Cellular therapy for myocardial injury has improved ventricular function in both animal and clinical studies, though the mechanism of benefit is unclear. This study was undertaken to examine the effects of cellular injection after infarction on myocardial elasticity. Coronary artery ligation of Lewis rats was followed by direct injection of human mesenchymal stem cells (MSCs) into the acutely ischemic myocardium. Two weeks postinfarct, myocardial elasticity was mapped by atomic force microscopy. MSC-injected hearts near the infarct region were twofold stiffer than myocardium from noninfarcted animals but softer than myocardium from vehicle-treated infarcted animals. After 8 wk, the following variables were evaluated: MSC engraftment and left ventricular geometry by histological methods, cardiac function with a pressure-volume conductance catheter, myocardial fibrosis by Masson Trichrome staining, vascularity by immunohistochemistry, and apoptosis by TdT-mediated dUTP nick-end labeling assay. The human cells engrafted and expressed a cardiomyocyte protein but stopped short of full differentiation and did not stimulate significant angiogenesis. MSC-injected hearts showed significantly less fibrosis than controls, as well as less left ventricular dilation, reduced apoptosis, increased myocardial thickness, and preservation of systolic and diastolic cardiac function. In summary, MSC injection after myocardial infarction did not regenerate contracting cardiomyocytes but reduced the stiffness of the subsequent scar and attenuated postinfarction remodeling, preserving some cardiac function. Improving scarred heart muscle compliance could be a functional benefit of cellular cardiomyoplasty.
Similar articles
- Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis.
Nagaya N, Fujii T, Iwase T, Ohgushi H, Itoh T, Uematsu M, Yamagishi M, Mori H, Kangawa K, Kitamura S. Nagaya N, et al. Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2670-6. doi: 10.1152/ajpheart.01071.2003. Epub 2004 Jul 29. Am J Physiol Heart Circ Physiol. 2004. PMID: 15284059 - Naive rat amnion-derived cell transplantation improved left ventricular function and reduced myocardial scar of postinfarcted heart.
Fujimoto KL, Miki T, Liu LJ, Hashizume R, Strom SC, Wagner WR, Keller BB, Tobita K. Fujimoto KL, et al. Cell Transplant. 2009;18(4):477-86. doi: 10.3727/096368909788809785. Cell Transplant. 2009. PMID: 19622235 - Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
Tang J, Xie Q, Pan G, Wang J, Wang M. Tang J, et al. Eur J Cardiothorac Surg. 2006 Aug;30(2):353-61. doi: 10.1016/j.ejcts.2006.02.070. Epub 2006 Jul 10. Eur J Cardiothorac Surg. 2006. PMID: 16829080 - Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver.
Awada HK, Hwang MP, Wang Y. Awada HK, et al. Biomaterials. 2016 Mar;82:94-112. doi: 10.1016/j.biomaterials.2015.12.025. Epub 2015 Dec 29. Biomaterials. 2016. PMID: 26757257 Free PMC article. Review. - Patient-specific computational modeling and magnetic nanoconstructs: tools for maximizing the efficacy of stem cell-based therapies.
Decuzzi P. Decuzzi P. Methodist Debakey Cardiovasc J. 2013 Oct-Dec;9(4):223-8. doi: 10.14797/mdcj-9-4-223. Methodist Debakey Cardiovasc J. 2013. PMID: 24298315 Free PMC article. Review.
Cited by
- Aligned human cardiac syncytium for in vitro analysis of electrical, structural, and mechanical readouts.
Napiwocki BN, Lang D, Stempien A, Zhang J, Vaidyanathan R, Makielski JC, Eckhardt LL, Glukhov AV, Kamp TJ, Crone WC. Napiwocki BN, et al. Biotechnol Bioeng. 2021 Jan;118(1):442-452. doi: 10.1002/bit.27582. Epub 2020 Oct 13. Biotechnol Bioeng. 2021. PMID: 32990953 Free PMC article. - Boosting Akt Pathway by Rupatadine Modulates Th17/Tregs Balance for Attenuation of Isoproterenol-Induced Heart Failure in Rats.
Ahmed LA, Mohamed AF, Abd El-Haleim EA, El-Tanbouly DM. Ahmed LA, et al. Front Pharmacol. 2021 Apr 30;12:651150. doi: 10.3389/fphar.2021.651150. eCollection 2021. Front Pharmacol. 2021. PMID: 33995066 Free PMC article. - Striated muscle function, regeneration, and repair.
Shadrin IY, Khodabukus A, Bursac N. Shadrin IY, et al. Cell Mol Life Sci. 2016 Nov;73(22):4175-4202. doi: 10.1007/s00018-016-2285-z. Epub 2016 Jun 6. Cell Mol Life Sci. 2016. PMID: 27271751 Free PMC article. Review. - A comparison of the reparative and angiogenic properties of mesenchymal stem cells derived from the bone marrow of BALB/c and C57/BL6 mice in a model of limb ischemia.
Cunha FF, Martins L, Martin PK, Stilhano RS, Han SW. Cunha FF, et al. Stem Cell Res Ther. 2013 Jul 26;4(4):86. doi: 10.1186/scrt245. Stem Cell Res Ther. 2013. PMID: 23890057 Free PMC article. - Congestive heart failure effects on atrial fibroblast phenotype: differences between freshly-isolated and cultured cells.
Dawson K, Wu CT, Qi XY, Nattel S. Dawson K, et al. PLoS One. 2012;7(12):e52032. doi: 10.1371/journal.pone.0052032. Epub 2012 Dec 14. PLoS One. 2012. PMID: 23251678 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical